Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing--invited commentary.
Budnitz
Daniel S
DS
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. dbudnitz@cdc.gov
D000368:Aged; D000075202:Contraindications; D017723:Drug Utilization Review / Q000592:standards*; D006801:Humans; D004366:Nonprescription Drugs; D017063:Outcome Assessment, Health Care; D055553:Prescription Drugs; D018570:Risk Assessment
D004366:Nonprescription Drugs; D055553:Prescription Drugs